KINNATE BIOPHARMA INC shareholders Q2 2023

KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 73 filers reported holding KINNATE BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.

KINNATE BIOPHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 9,671,643$29,305,07814.41%
Vida Ventures Advisors, LLC 2,207,772$6,689,5498.73%
Foresite Capital Management V, LLC 3,525,957$10,683,6507.80%
Lynx1 Capital Management LP 2,048,736$6,207,6704.07%
Nextech Invest Ltd. 2,329,480$7,058,3242.40%
Orbimed Advisors 8,009,729$24,269,4790.44%
Novo Holdings A/S 815,707$2,471,5920.19%
HARVARD MANAGEMENT CO INC 462,418$1,4010.14%
GSA CAPITAL PARTNERS LLP 240,343$7280.07%
Boxer Capital, LLC 491,000$1,4880.07%
DAFNA Capital Management LLC 80,179$242,9420.07%
Rock Springs Capital Management LP 746,973$2,263,3280.05%
XTX Topco Ltd 72,300$219,0690.04%
CORNERCAP INVESTMENT COUNSEL INC 68,040$206,1610.04%
VIKING GLOBAL INVESTORS LP 1,820,462$5,516,0000.02%
Artal Group S.A. 125,000$3790.01%
Y-Intercept (Hong Kong) Ltd 33,702$102,1170.01%
PRELUDE CAPITAL MANAGEMENT, LLC 28,754$87,1250.01%
OCCUDO QUANTITATIVE STRATEGIES LP 15,435$46,7680.01%
ACADIAN ASSET MANAGEMENT LLC 430,802$1,3040.01%
External links

This page lists KINNATE BIOPHARMA INC's shareholders in Q2 2023. To view KINNATE BIOPHARMA INC's shareholder history, click here.